Among the markers of inflammation and endothelial dysfunction in patients with and without MetS, males with MetS had significantly higher levels of IL-6 and hsCRP than the non-MetS group, and also had higher E-selectin levels but without significance. Here, IL6 is linked to metabolic syndrome.